1. Astragalus polysaccharide, a component of traditional Chinese medicine, inhibits muscle cell atrophy (cachexia) in an in vivo and in vitro rat model of chronic renal failure by activating the ubiquitin-proteasome pathway
   Zhenbo Geng et al, 2017, Experimental and Therapeutic Medicine CrossRef
2. Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
   Pasquale Esposito et al, 2020, Journal of Atherosclerosis and Thrombosis CrossRef
3. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry
   Carlos R. Ramírez Medina et al, 2023, Clinical Proteomics CrossRef
4. Absence of ULK1 decreases AMPK activity in the kidney, leading to chronic kidney disease progression
   Tomoki Yanagi et al, 2023, Genes to Cells CrossRef
5. Identification of differential gene expression patterns in human arteries from patients with chronic kidney disease
   Jane Stubbe et al, 2018, American Journal of Physiology-Renal Physiology CrossRef